972 results on '"Weir, Christopher"'
Search Results
2. A complex ePrescribing antimicrobial stewardship-based (ePAMS+) intervention for hospitals: mixed-methods feasibility trial results
3. Protocol for a pilot cluster randomised controlled trial of PRoGRAM-A (preventing gambling-related harm in adolescents): a secondary school-based social network intervention
4. Evaluation of Digitalisation in Healthcare and the Quantification of the “Unmeasurable”
5. Uniform or Sex-Specific Cardiac Troponin Thresholds to Rule Out Myocardial Infarction at Presentation
6. Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial
7. Epidemiology of self-limited epilepsy with centrotemporal spikes (SeLECTS): A population study using primary care records
8. Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study
9. Statistical analysis plan for the motor neuron disease systematic multi-arm adaptive randomised trial (MND-SMART)
10. A complex ePrescribing-based Anti-Microbial Stewardship (ePAMS+) intervention for hospitals combining technological and behavioural components: protocol for a feasibility trial
11. Comparison of neurodevelopmental, educational and adult socioeconomic outcomes in offspring of women with and without epilepsy: A systematic review and meta-analysis
12. Socioeconomic status in adulthood of children with and without a history of seizures: A retrospective cohort study
13. Machine Learning for Myocardial Infarction Compared With Guideline-Recommended Diagnostic Pathways
14. Synergistic effect of low-voltage nanosecond-pulsed discharges for scramjet cavity ignition
15. High-sensitivity cardiac troponin and the diagnosis of myocardial infarction in patients with kidney impairment
16. A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials
17. Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review
18. The effect of digital antimicrobial stewardship programmes on antimicrobial usage, length of stay, mortality and cost
19. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
20. Uniform or Sex-Specific Cardiac Troponin Thresholds to Rule Out Myocardial Infarction at Presentation
21. Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trial
22. Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial
23. Awareness of fetal movements and care package to reduce fetal mortality (AFFIRM): a trial-based and model-based cost-effectiveness analysis from a stepped wedge, cluster-randomised trial
24. Practical guidance for planning resources required to support publicly-funded adaptive clinical trials
25. Multiple secondary outcome analyses: precise interpretation is important
26. Biochemical and biophysical investigations into key malaria parasite proteins
27. Validation of the myocardial-ischaemic-injury-index machine learning algorithm to guide the diagnosis of myocardial infarction in a heterogenous population: a prespecified exploratory analysis
28. Comparing performance on the Months of the Year Backwards test in hospitalised patients with delirium, dementia, and no cognitive impairment: an exploratory study
29. Macrophage Therapy for Acute Liver Injury (MAIL): a Phase 1 Randomised, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Activity of Allogeneic Alternatively Activated Macrophages in Patients with Paracetamol-induced Acute Liver Injury.
30. Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome
31. The Adaptive designs CONSORT Extension (ACE) statement : a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
32. Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments.
33. Selecting Reducing Agents for Native Mass Spectrometry
34. Exploration of Metabolomic Markers Associated With Declining Kidney Function in People With Type 2 Diabetes Mellitus
35. Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the UK
36. Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials project
37. Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial)
38. The need for reporting guidelines for early phase dose-finding trials: Dose-Finding CONSORT Extension
39. Protocol for a pilot cluster randomised controlled trial of PRoGRAM-A (Preventing gambling related harm in adolescents): a secondary school based social network intervention
40. Protocol of a randomised trial of teriparatide followed by zoledronic acid to reduce fracture risk in adults with osteogenesis imperfecta
41. Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance
42. Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study
43. Frailty assessment and risk prediction by GRACE score in older patients with acute myocardial infarction
44. How to design a dose-finding study using the continual reassessment method
45. Exploration of Metabolomic Markers Associated With Declining Kidney Function in People With Type 2 Diabetes Mellitus.
46. High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction
47. Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials:the DEFINE study
48. Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate endpoints in trials:A scoping review
49. Early PREdiction of sepsis using leukocyte surface biomarkers: the ExPRES-sepsis cohort study
50. Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.